Related Experiment Videos
Mycophenolate mofetil: new applications for this immunosuppressant
1Division of Rheumatology, Mayo Clinic, Rochester, Minnesota 55905, USA.
Summary
Mycophenolate mofetil is an immunosuppressive drug used in organ transplants and increasingly for inflammatory conditions. It shows promise for treating autoimmune diseases like systemic lupus erythematosus.
Area of Science:
- Immunopharmacology
- Transplant medicine
- Rheumatology
Background:
- Mycophenolate mofetil is an established immunosuppressive agent.
- Its use has expanded beyond organ transplantation.
- Inflammatory and autoimmune conditions are increasingly treated with this agent.
Purpose of the Study:
- To review the pharmacokinetics and mechanism of action of mycophenolate mofetil.
- To discuss the potential toxicities associated with its use.
- To explore current and future applications of mycophenolate mofetil in medicine.
Main Methods:
- Comprehensive review of the current medical literature.
- Analysis of pharmacokinetic data.
- Evaluation of clinical trial results and case studies.
Main Results:
- Mycophenolate mofetil demonstrates significant immunosuppressive properties.
- Established efficacy in preventing organ transplant rejection.
- Emerging evidence supports its utility in managing various inflammatory diseases.
Conclusions:
- Mycophenolate mofetil is a valuable therapeutic option for inflammatory conditions.
- Systemic lupus erythematosus is a key condition where mycophenolate mofetil shows potential.
- Further research is warranted to fully elucidate its long-term benefits and applications.